Biosimilars

Biosimilars: Is the Market Getting Too Much Attention?

Biosimilars: Is the Market Getting Too Much Attention?

By Zachary Brennan

As anticipation swells over how the biosimilar market will shape up in the US, some contract biologic manufacturing executives don’t seem to think the size of the market is worth all of the hype yet.

Follow us

Products

View more

Webinars